Tectonic Therapeutic | AVRO - Eps Gewinn Pro Aktie

Aktienkurs
28.54
Täglich Wechseln
0.10 0.35%
Monatlich
-8.11%
Jährlich
35.32%
Q2 Prognose
27.93




Eps Veränderung Datum
Akebia Therapeutics USD -0.04 0.04 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Celltrion KRW 1.55K 735.24 2026-03
Cspc Pharmaceutical CNY 0 0.08 2025-12
Deva Holding AS TRY 2.92 1.6 2023-09
Dianthus Therapeutics USD -1.43 0.46 2025-12
Divis Laboratories Ltd INR 21.98 3.99 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Kangmei Pharma CNY 0 0 2025-09
Karyopharm Therapeutics USD -2.22 2.07 2025-12
Knight Therapeutics CAD -0.09 0.12 2025-12
Laboratorios Farma EUR 1.96 0.71 2023-12
MacroGenics USD -0.22 0.49 2025-12
Malin Corporation EUR -0.06 0.1 2023-12
Medical Developments International AUD 0 0 2025-12
Neuren Pharmaceuticals AUD 0.12 0.06 2025-12
Organigram Holdings CAD -0.16 0.02 2025-12
Ovoca Bio EUR -0.06 0.01 2025-06
Pfizer USD 0.66 0.21 2025-12
Pharma Mar EUR 3.34 3.57 2025-12
Qiagen NV USD 0.52 0.01 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sarepta Therapeutics USD -3.58 3.45 2025-12
Sartorius EUR 1.2 0.06 2026-03
Sino Biopharmaceutical CNY -0.06 0.22 2025-12
Takeda JPY 65.74 73.57 2025-12
Tilray USD -0.41 0.4 2025-12
Zealand Pharma A/S -8.34 2.6 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 2025-09